» Articles » PMID: 31817450

Exosomal Thrombospondin-1 Disrupts the Integrity of Endothelial Intercellular Junctions to Facilitate Breast Cancer Cell Metastasis

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2019 Dec 11
PMID 31817450
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Transendothelial migration of malignant cells plays an essential role in tumor progression and metastasis. The present study revealed that treating human umbilical vein endothelial cells (HUVECs) with exosomes derived from metastatic breast cancer cells increased the number of cancer cells migrating through the endothelial cell layer and impaired the tube formation of HUVECs. Furthermore, the expression of intercellular junction proteins, including vascular endothelial cadherin (VE-cadherin) and zona occluden-1 (ZO-1), was reduced significantly in HUVECs treated with carcinoma-derived exosomes. Proteomic analyses revealed that thrombospondin-1 (TSP1) was highly expressed in breast cancer cell MDA-MB-231-derived exosomes. Treating HUVECs with TSP1-enriched exosomes similarly promoted the transendothelial migration of malignant cells and decreased the expression of intercellular junction proteins. TSP1-down regulation abolished the effects of exosomes on HUVECs. The migration of breast cancer cells was markedly increased in a zebrafish in vivo model injected with TSP1-overexpressing breast cancer cells. Taken together, these results suggest that carcinoma-derived exosomal TSP1 facilitated the transendothelial migration of breast cancer cells via disrupting the intercellular integrity of endothelial cells.

Citing Articles

Cancer cells impact the microrheology of endothelial cells during physical contact or through paracrine signalling.

Kefala G, Tsvirkun D, Laurent V, Verdier C Sci Rep. 2025; 15(1):8064.

PMID: 40055419 PMC: 11889160. DOI: 10.1038/s41598-025-92422-w.


Recent Advances and Mechanism of Nanomaterials Promoting Tumor Metastasis.

Wang W, Pang X, Dong M, Li R, Liu Z, Liang Y Environ Health (Wash). 2024; 1(6):367-382.

PMID: 39474052 PMC: 11503957. DOI: 10.1021/envhealth.3c00132.


Enigmatic exosomal connection in lung cancer drug resistance.

Patra S, Sahoo R, Biswal S, Panda S, Biswal B Mol Ther Nucleic Acids. 2024; 35(2):102177.

PMID: 38617976 PMC: 11015513. DOI: 10.1016/j.omtn.2024.102177.


Protein cargo in extracellular vesicles as the key mediator in the progression of cancer.

Hanelova K, Raudenska M, Masarik M, Balvan J Cell Commun Signal. 2024; 22(1):25.

PMID: 38200509 PMC: 10777590. DOI: 10.1186/s12964-023-01408-6.


Progress in cancer neuroscience.

Lan Y, Zou S, Wang W, Chen Q, Zhu Y MedComm (2020). 2023; 4(6):e431.

PMID: 38020711 PMC: 10665600. DOI: 10.1002/mco2.431.


References
1.
Tzeng H, Tsai C, Yen Y, Cheng H, Chen Y, Pu S . Dysregulation of Rab37-Mediated Cross-talk between Cancer Cells and Endothelial Cells via Thrombospondin-1 Promotes Tumor Neovasculature and Metastasis. Clin Cancer Res. 2017; 23(9):2335-2345. DOI: 10.1158/1078-0432.CCR-16-1520. View

2.
Benn A, Bredow C, Casanova I, Vukicevic S, Knaus P . VE-cadherin facilitates BMP-induced endothelial cell permeability and signaling. J Cell Sci. 2015; 129(1):206-18. PMC: 4732303. DOI: 10.1242/jcs.179960. View

3.
Yuan A, Farber E, Rapoport A, Tejada D, Deniskin R, Akhmedov N . Transfer of microRNAs by embryonic stem cell microvesicles. PLoS One. 2009; 4(3):e4722. PMC: 2648987. DOI: 10.1371/journal.pone.0004722. View

4.
Dvorak H, Weaver V, Tlsty T, Bergers G . Tumor microenvironment and progression. J Surg Oncol. 2011; 103(6):468-74. PMC: 3277953. DOI: 10.1002/jso.21709. View

5.
Firlej V, Mathieu J, Gilbert C, Lemonnier L, Nakhle J, Gallou-Kabani C . Thrombospondin-1 triggers cell migration and development of advanced prostate tumors. Cancer Res. 2011; 71(24):7649-58. DOI: 10.1158/0008-5472.CAN-11-0833. View